These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33422806)

  • 1. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
    Manzo C; Serra-Mestres J; Isetta M; Castagna A
    Med Hypotheses; 2021 Feb; 147():110479. PubMed ID: 33422806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and olfactory dysfunction: a looming wave of dementia?
    Kay LM
    J Neurophysiol; 2022 Aug; 128(2):436-444. PubMed ID: 35894511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.
    Butowt R; von Bartheld CS
    Neuroscientist; 2021 Dec; 27(6):582-603. PubMed ID: 32914699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Molecular Basis of Olfactory Dysfunction in COVID-19 and Long COVID.
    Anastassopoulou C; Davaris N; Ferous S; Siafakas N; Boufidou F; Anagnostopoulos K; Tsakris A
    Lifestyle Genom; 2024; 17(1):42-56. PubMed ID: 38749402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of olfactory dysfunction and progression to dementia: A 12-year population-based study.
    Laukka EJ; Ekström I; Larsson M; Grande G; Fratiglioni L; Rizzuto D
    Alzheimers Dement; 2023 Jul; 19(7):3019-3027. PubMed ID: 36689643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.
    Ojha P; Dixit A
    Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):462-473. PubMed ID: 35090056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.
    Saussez S; Lechien JR; Hopkins C
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2187-2191. PubMed ID: 32909060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and anosmia: The story so far.
    Meng X; Pan Y
    Ear Nose Throat J; 2024 May; 103(5):NP312-NP320. PubMed ID: 34587819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal course of COVID-19 anosmia and relation to other clinical symptoms.
    Altundag A; Saatci O; Sanli DET; Duz OA; Sanli AN; Olmuscelik O; Temirbekov D; Kandemirli SG; Karaaltin AB
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1891-1897. PubMed ID: 33237475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study.
    Miyake MM; Valera FCP; Martins RB; Compagnoni IM; Fantucci MZ; Murashima AAB; da Silva LECM; de Lima TM; de Souza MVO; Melo SR; Dolci RLL; Floriano CG; de Campos CAC; Nakanishi M; Freire GSM; Valente AL; Fornazieri MA; da Silva JLB; Anzolin LK; Issa MJA; Souza TV; Lima BA; SantAnna GD; Abreu CB; Sakano E; Cassettari AJ; Avelino MAG; Goncalves MC; de Camargo LA; Romano FR; Alves RD; Roithmann R; Redeker NK; Filho LLB; Dassi CS; Meurer ATO; Garcia DM; Aragon DC; Tepedino MS; Succar ACS; Vianna PM; Dos Santos MCJ; Filho RHR; Kosugi EM; Villa JF; Gregorio LL; Piltcher OB; Meotti CD; Tamashiro E; Arruda E; Anselmo Lima WT
    Rhinology; 2024 Feb; 62(1):55-62. PubMed ID: 37772802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments.
    Najafloo R; Majidi J; Asghari A; Aleemardani M; Kamrava SK; Simorgh S; Seifalian A; Bagher Z; Seifalian AM
    ACS Chem Neurosci; 2021 Oct; 12(20):3795-3805. PubMed ID: 34609841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Olfactory Dysfunction and Critical Illness and Mortality in COVID-19: A Meta-analysis.
    Goshtasbi K; Pang J; Lehrich BM; Vasudev M; Birkenbeuel JL; Abiri A; Kuan EC
    Otolaryngol Head Neck Surg; 2022 Feb; 166(2):388-392. PubMed ID: 34030510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa.
    Shahbaz MA; Kuivanen S; Lampinen R; Mussalo L; Hron T; Závodná T; Ojha R; Krejčík Z; Saveleva L; Tahir NA; Kalapudas J; Koivisto AM; Penttilä E; Löppönen H; Singh P; Topinka J; Vapalahti O; Chew S; Balistreri G; Kanninen KM
    J Neuroinflammation; 2023 Dec; 20(1):299. PubMed ID: 38098019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.
    Las Casas Lima MH; Cavalcante ALB; Leão SC
    Braz J Otorhinolaryngol; 2022; 88(5):794-802. PubMed ID: 33965353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The alleged mechanisms of olfactory disorders in the new coronavirus infection].
    Lashch NY; Yunyaev AR; Evsyukova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(2):7-11. PubMed ID: 36843453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.
    Doty RL
    Trends Mol Med; 2022 Sep; 28(9):781-794. PubMed ID: 35810128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-COVID olfactory dysfunction: allele E4 of apolipoprotein E as a possible protective factor.
    Oliveira DN; Tavares-Júnior JWL; Feitosa WLQ; Cunha LCV; Gomes CMP; Moreira-Nunes CA; Silva JBSD; Sousa AVM; Gaspar SB; Sobreira EST; Oliveira LLB; Montenegro RC; Moraes MEA; Sobreira-Neto MA; Braga-Neto P
    Arq Neuropsiquiatr; 2024 Sep; 82(9):1-7. PubMed ID: 39025107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of anosmia/hyposmia in post-COVID-19 patients: a cross-sectional study in an eastern province of Saudi Arabia.
    Mohamed R; Alsuhibani R; Almasaoud H; Alsubhi S; Alabdulazeem L; Alzahrani N; Alsaif S; Al Ghamdi K; Al-Asoom L
    Acta Biomed; 2023 Dec; 94(6):e2023259. PubMed ID: 38054673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.